Association of Cannabinoid Specialists
Adam Abodeely MD, MBA, serves as CEO and Co-Founder of Coral Cove Wellness Resort and has held various key positions in the cannabinoid industry, including Board Member for the Association of Cannabis Specialists and Chief Medical Officer for Reserve:MD and the Cannabinoid Industry Association. In the healthcare sector, Adam Abodeely is the Associate Chief Medical Officer at Adirondack Health and an Assistant Professor and Clinical Faculty member at multiple hospitals in New York, where Adam instructs general surgery residents. As the Founder, Owner, and Surgeon of Adirondack Gastrointestinal and Colorectal Surgery, Adam Abodeely leads a skilled team to provide top-quality care while managing operational finances. Adam Abodeely holds an MBA from Northwestern University and multiple medical degrees and certifications from prestigious institutions, contributing to a robust background in medicine and business.
This person is not in any teams
This person is not in any offices
Association of Cannabinoid Specialists
The Association of Cannabis Specialists ensures the highest standards in the practice of cannabis medicine, safeguards patient care with clinical best practices, and interfaces with other stakeholders in the cannabis community. We believe that patients are uniquely vulnerable and have very different needs than recreational users. We provide evidence and experience-based education for patients, cannabis clinicians, referring clinicians, and lawmakers to help them understand cannabis medicine and make informed decisions. We are a political organization striving to implement best practices in the laws and regulations at the federal, state, and international levels. Our Core Values: • Patients are a vulnerable group who deserve the highest standard of medical care and products. • Recreational use is not the same as medical use. These groups have different goals and needs and must be addressed separately. • Prohibition of cannabis is a major public health hazard that has failed to decrease drug use and has led to unsupportable consequences. • Cannabis is medicine. It should be regulated like other medications and be available by prescription including in botanical form. • Cannabis products should not make unsubstantiated medical claims. Products should be required to meet strict standards of safety, bioavailability, and efficacy. • Dispensaries should operate like pharmacies. They should provide products that are safe and effective. They should not provide medical advice to patients. They should not contradict patients’ clinicians’ orders.